中东和非洲疫苗佐剂市场预测至 2030 年 – 区域分析 – 按佐剂类别（矿物盐佐剂、乳液佐剂、脂质体佐剂等）和类型（人用疫苗佐剂和兽用疫苗佐剂）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 73    |    Report Code: BMIRE00031084    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Vaccine Adjuvants Market
Free Sample Buy Now
2022 年中东和非洲疫苗佐剂市场价值为 7894 万美元，预计到 2030 年将达到 1.8715 亿美元；预计 2022 年至 2030 年的复合年增长率为 11.4%。

技术进步推动中东和非洲疫苗佐剂市场发展

目前，铝盐或凝胶基佐剂主要用于许可疫苗。单磷酰脂质 A (MPL) 佐剂和疏水共聚物就是这些成分的例子。疏水微球在疫苗生产过程中带来挑战。这些问题包括许多环境废物处理和污染问题，而且费时、费钱、效率低下。因此，制造商正强调开发新技术以避免使用有机溶剂。例如，Aphios 的疫苗佐剂技术包含纳米技术，其生产包括超临界、临界或近临界流体，含或不含极性助溶剂，如乙醇 [称为超流体 (SFS)]。可生物降解的生物聚合物溶解在 SFS 中，并与亚单位疫苗在水溶液中或作为纳米颗粒浆液混合。因此，正在开发此类新型疫苗佐剂技术，通过新工艺制造可生物降解的聚合物纳米球 (PNS)，这使疫苗制造商可以排除使用有机溶剂。因此，技术进步可能会在未来几年为疫苗佐剂市场带来新的趋势。

中东和非洲疫苗佐剂市场概览

中东和非洲疫苗佐剂市场已细分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。产品批准数量的增加是沙特阿拉伯疫苗佐剂市场实现正增长的主要驱动力。SAFDA 的产品批准将增强佐剂疫苗的采用，并加速其在未来几年在沙特阿拉伯的采用，推动市场从 2020 年到 2030 年的增长。

中东和非洲疫苗佐剂市场收入和预测到 2030 年（百万美元）

中东和非洲疫苗佐剂市场细分

中东和非洲疫苗佐剂市场分为佐剂类别、类型和国家。

根据佐剂类别，中东和非洲疫苗佐剂市场分为矿物盐佐剂、乳剂佐剂、脂质体佐剂等。 2022 年，矿物盐佐剂部分占据了中东和非洲疫苗佐剂市场的最大份额。

按类型划分，中东和非洲疫苗佐剂市场分为人用疫苗佐剂和兽用疫苗佐剂。2022 年，人用疫苗佐剂部分占据了中东和非洲疫苗佐剂市场的较大份额。

按国家划分，中东和非洲疫苗佐剂市场分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。2022 年，沙特阿拉伯占据了中东和非洲疫苗佐剂市场的主导份额。

Croda International Plc；CSL Ltd；GSK Plc；Novavax Inc；和 Phibro Animal Health Corp 是中东和非洲疫苗佐剂市场的一些领先公司。

Middle East & Africa Vaccine Adjuvants Strategic Insights

Strategic insights for Middle East & Africa Vaccine Adjuvants involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-vaccine-adjuvants-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Vaccine Adjuvants Report Scope

Report Attribute Details
Market size in 2022 US$ 78.94 Million
Market Size by 2030 US$ 187.15 Million
Global CAGR (2022 - 2030) 11.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 佐剂类
  • 矿物盐佐剂
  • 乳剂佐剂
  • 脂质体佐剂
By 类型
  • 人用疫苗佐剂
  • 兽用疫苗佐剂
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Croda International Plc
  • CSL Ltd
  • GSK Plc
  • Novavax Inc
  • Phibro Animal Health Corp
    		•
    Get more information on this report

    Middle East & Africa Vaccine Adjuvants Regional Insights

    The regional scope of Middle East & Africa Vaccine Adjuvants refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-vaccine-adjuvants-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Vaccine Adjuvants Market

    • Croda International Plc
    • CSL Ltd
    • GSK Plc
    • Novavax Inc
    • Phibro Animal Health Corp
    Frequently Asked Questions
    How big is the Middle East & Africa Vaccine Adjuvants Market?

    The Middle East & Africa Vaccine Adjuvants Market is valued at US$ 78.94 Million in 2022, it is projected to reach US$ 187.15 Million by 2030.

    What is the CAGR for Middle East & Africa Vaccine Adjuvants Market by (2022 - 2030)?

    As per our report Middle East & Africa Vaccine Adjuvants Market, the market size is valued at US$ 78.94 Million in 2022, projecting it to reach US$ 187.15 Million by 2030. This translates to a CAGR of approximately 11.4% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Vaccine Adjuvants Market report typically cover these key segments-

  • 佐剂类 (矿物盐佐剂, 乳剂佐剂, 脂质体佐剂)
  • 类型 (人用疫苗佐剂, 兽用疫苗佐剂)

    • What is the historic period, base year, and forecast period taken for Middle East & Africa Vaccine Adjuvants Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Vaccine Adjuvants Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Middle East & Africa Vaccine Adjuvants Market?

    The Middle East & Africa Vaccine Adjuvants Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Croda International Plc
  • CSL Ltd
  • GSK Plc
  • Novavax Inc
  • Phibro Animal Health Corp
    • Who should buy this report?

    The Middle East & Africa Vaccine Adjuvants Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Vaccine Adjuvants Market value chain can benefit from the information contained in a comprehensive market report.

    middle-east-and-africa-vaccine-adjuvants-market